ABBVIE INC
Aktie · US00287Y1091 · ABBV · A1J84E (XNYS)
193,35 USD
17.02.2025 17:35
Aktuelle Kurse von ABBVIE INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
![]() XETRA |
4AB.DE
|
EUR
|
17.02.2025 17:35
|
184,34 EUR
| 185,08 EUR | -0,40 % |
![]() NYSE |
ABBV
|
USD
|
15.02.2025 00:22
|
192,87 USD
| 193,45 USD | -0,30 % |
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,18 % | 1,51 % | 11,24 % | 17,11 % | -0,35 % | 8,86 % | 103,12 % |
Firmenprofil zu ABBVIE INC Aktie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Investierte Fonds
Folgende Fonds haben in investiert: ABBVIE INC investiert:
Fonds | Vol. in Mio 9.198,56 | Anteil (%) 2,52 % |
Fonds | Vol. in Mio 2.322,89 | Anteil (%) 1,89 % |
Fonds | Vol. in Mio 801,98 | Anteil (%) 1,68 % |
Fonds | Vol. in Mio 3.006,31 | Anteil (%) 1,16 % |
Fonds | Vol. in Mio 12.810,58 | Anteil (%) 1,06 % |
Unternehmensdaten
Name ABBVIE INC
Firma AbbVie Inc.
Symbol ABBV
Website https://www.abbvie.com
Heimatbörse
NYSE

WKN A1J84E
ISIN US00287Y1091
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Robert A. Michael CPA
Marktkapitalisierung 341 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 50,0 T
Adresse 1 North Waukegan Road, 60064-6400 North Chicago
IPO Datum 2013-01-02
Dividenden von 'ABBVIE INC'
Ex-Datum | Dividende pro Aktie |
---|---|
15.01.2025 | 1,64 USD |
15.10.2024 | 1,55 USD |
15.07.2024 | 1,55 USD |
12.04.2024 | 1,55 USD |
12.01.2024 | 1,55 USD |
12.10.2023 | 1,48 USD |
13.07.2023 | 1,48 USD |
13.04.2023 | 1,48 USD |
12.01.2023 | 1,48 USD |
13.10.2022 | 1,41 USD |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 4AB.F |
NYSE | ABBV |
XETRA | 4AB.DE |
Weitere Aktien
Investoren die ABBVIE INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.